Second, an anti-CD47 antibody may eliminate tumor cells through Fc-dependent mechanisms, such as antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC). Here, CD47 is linked to neoplasm.